Rufinamide Suspension
Product Images NDC 72205-038

This text provides information on Rufinamide Oral Suspension indicated for oral administration. The suspension contains 40mg of Rufinamide per mL. The pharmacist is advised to dispense the enclosed Medication Guide to patients. It is important to shake the bottle well before each use. The dosage and usage instructions should be followed as per the prescribing information. A warning is given to keep the medication out of the reach of children. The suspension should be discarded within 90 days of opening. Storage instructions recommend keeping the medication at 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). The product is manufactured by MSN Pharmaceuticals Inc. in Piscataway, NJ, and distributed by Novadoz Pharmaceuticals LLC. The contact number for Novadoz Pharmaceuticals LLC is 855-NOVADOZ (668-2369). The issue date of the information provided is 01/2022.*

This is a description of a medication called Rufinamide Oral Suspension, supplied in a 480 mL bottle with two 20 mL oral syringes for administration. The medication contains 40 mg of Rufinamide per mL. It is important to shake the bottle well before each use and to see the enclosed full prescribing information for administration instructions. The medication should be discarded within 90 days of opening and stored at a controlled room temperature. The product is for oral administration only, and the pharmacist should dispense a medication guide to each patient. The medication is distributed by Novadoz Pharmaceuticals LLC.*

Not available.*